ALPCO Releases STELLUX™ Chemiluminescent Human Intact Proinsulin ELISA by PR.com

VIEWS: 10 PAGES: 2

ALPCO has launched their new STELLUX™ Chemi Human Intact Proinsulin ELISA, the latest addition to their chemiluminescent product line.

More Info
									ALPCO Releases STELLUX™ Chemiluminescent Human Intact Proinsulin
ELISA

ALPCO has launched their new STELLUX™ Chemi Human Intact Proinsulin ELISA, the latest
addition to their chemiluminescent product line.

Salem, NH, February 18, 2014 --(PR.com)-- ALPCO has launched their new STELLUX™
Chemiluminescent Human Intact Proinsulin ELISA, the latest assay to be launched in the company's
STELLUX™ Chemiluminescent product line. The new Human Intact Proinsulin ELISA features a broad
dynamic range (5-3,000 pg/mL) which is ideal for measuring normal to pre-diabetic samples. The assay
also boasts a superior sensitivity of
“We're extremely proud of the development of the STELLUX™ assay range thus far,” says ALPCO'S
President, Sean Conley. “This chemiluminescent platform has enabled our R&D staff to provide solutions
to problems that have challenged our customers for years. As we expand the STELLUX™ product line,
each new assay will be designed with similar customer-centric goals in mind.”

Each production lot within the STELLUX™ portfolio is offered with a lot specific validation summary.
“The validation summary includes specifications such as functional sensitivity, inter- and intra-assay
precision, LLOQ, ULOQ, and a cross lot correlation panel for inter-lot comparability,” explains Martin
Blankfard, Vice President of Scientific Operations. “This is an element many of our pharma customers
have been seeking for some time now, and we're pleased to answer their call.”

The next STELLUX™ products to be released in the coming months will include assays for C-peptide
and GLP-1.

About ALPCO
ALPCO offers a wide range of testing solutions, providing scientists and healthcare professionals with
vital tools for advancing research and improving quality of care. Our product portfolio includes
applications for immunoassays, HPLC, LC-MS/MS, purified antibodies, recombinant proteins, flow
cytometry reagents and our new STELLUX™ chemiluminescent assay platform. The STELLUX™
assays from ALPCO are for Research Use Only. www.alpco.com




                                                  Page 1/2
                               PR.com Press Release Distribution   Terms of Use
Contact Information:
ALPCO
Tal Murthy, PhD
1-800-592-5726 x229
Contact via Email
www.alpco.com


Online Version of Press Release:
You can read the online version of this press release at: http://www.pr.com/press-release/542427


News Image:




                                                  Page 2/2
                               PR.com Press Release Distribution   Terms of Use

								
To top